Related references
Note: Only part of the references are listed.Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma
Seiya Hattori et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis
Meghedi N. Aghourian et al.
BLOOD (2016)
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L. Zhou et al.
ONCOGENE (2016)
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
Le Qu et al.
CANCER CELL (2016)
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
Christopher J. Tape et al.
CELL (2016)
Development and maturation of natural killer cells
Theresa L. Geiger et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer
Hawa Nalwoga et al.
PLOS ONE (2016)
Hypoxic control of metastasis
Erinn B. Rankin et al.
SCIENCE (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
Miles A. Miller et al.
CANCER DISCOVERY (2016)
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
Min-Shu Hsieh et al.
ONCOTARGET (2016)
Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
Jian Liu et al.
PLOS ONE (2016)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Toni M. Brand et al.
CLINICAL CANCER RESEARCH (2015)
Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma
Patrick Reichl et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma
Juliano D. Paccez et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
Polarization of tumor-associated macrophages and Gas6/Axl signaling in oral squamous cell carcinoma
Kuo-Chou Chiu et al.
ORAL ONCOLOGY (2015)
被撤回的出版物: MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL (Retracted article. See April, 2017)
Rui Li et al.
TUMOR BIOLOGY (2015)
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome
Katia Rea et al.
ONCOTARGET (2015)
Kinome-wide shRNA Screen Identifies the Receptor Tyrosine Kinase AXL as a Key Regulator for Mesenchymal Glioblastoma Stem-like Cells
Peng Cheng et al.
STEM CELL REPORTS (2015)
Axl Phosphorylates Elmo Scaffold Proteins To Promote Rac Activation and Cell Invasion
Afnan Abu-Thuraia et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
J. S. Waizenegger et al.
LEUKEMIA (2015)
Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma
Tao Jiang et al.
PLOS ONE (2015)
AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Catherine Wilson et al.
CANCER RESEARCH (2014)
AXL Mediates Resistance to Cetuximab Therapy
Toni M. Brand et al.
CANCER RESEARCH (2014)
AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
Philip D. Dunne et al.
CLINICAL CANCER RESEARCH (2014)
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
S. P. Whitman et al.
LEUKEMIA (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
Mihalis S. Kariolis et al.
NATURE CHEMICAL BIOLOGY (2014)
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
S. Ammoun et al.
ONCOGENE (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma
M. A. Cichon et al.
ONCOGENE (2014)
Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
Gunnar Johansson et al.
PLOS ONE (2014)
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Erinn B. Rankin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MicroRNA-34a: a potential therapeutic target in human cancer
X. J. Li et al.
CELL DEATH & DISEASE (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma
Pu-xiang Chen et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2013)
Higher Expression of Receptor Tyrosine Kinase Axl, and Differential Expression of its Ligand, Gas6, Predict Poor Survival in Lung Adenocarcinoma Patients
Masashi Ishikawa et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Gas6/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma. patients
Ju Han et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma
Isabel Ben-Batalla et al.
BLOOD (2013)
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
D. J. Pinato et al.
BRITISH JOURNAL OF CANCER (2013)
ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer
Jun Hong et al.
CANCER RESEARCH (2013)
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Keith M. Giles et al.
MOLECULAR CANCER THERAPEUTICS (2013)
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Aaron S. Meyer et al.
SCIENCE SIGNALING (2013)
Biology of the TAM Receptors
Greg Lemke
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Cabozantinib as a Novel Therapy for Renal Cell Carcinoma
Ulka Vaishampayan
CURRENT ONCOLOGY REPORTS (2013)
Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer
Michelle Buehler et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Axl Is a Prognostic Marker in Oral Squamous Cell Carcinoma
Chien-Hsing Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate Cancer
Anjali Mishra et al.
MOLECULAR CANCER RESEARCH (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy
Asish K. Ghosh et al.
BLOOD (2011)
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
AXL regulates mesothelioma proliferation and invasiveness
W-B Ou et al.
ONCOGENE (2011)
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
G. Mudduluru et al.
ONCOGENE (2011)
Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
Sonja Loges et al.
BLOOD (2010)
Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma
Ren Liu et al.
BLOOD (2010)
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma
Hector Alvarez et al.
CANCER BIOLOGY & THERAPY (2010)
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Erinn B. Rankin et al.
CANCER RESEARCH (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Rachel Ma Linger et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer
Giridhar Mudduluru et al.
MOLECULAR CANCER RESEARCH (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
Il-Kyoo Park et al.
BLOOD (2009)
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
Jan-Bart M. Koorstra et al.
CANCER BIOLOGY & THERAPY (2009)
Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival
Anna Gustafsson et al.
CLINICAL CANCER RESEARCH (2009)
Lack of Protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis
Tal Burstyn-Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The human receptor tyrosine kinase Axl gene-promoter characterization and regulation of constitutive expression by Sp1, Sp3 and CpG methylation
Giridhar Mudduluru et al.
BIOSCIENCE REPORTS (2008)
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
Chih-Chen Hong et al.
CANCER LETTERS (2008)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
K-Y Tai et al.
ONCOGENE (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway
Tateo Sawabu et al.
MOLECULAR CARCINOGENESIS (2007)
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases
Anouk Caraux et al.
NATURE IMMUNOLOGY (2006)
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
P Vajkoczy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of Axl in lung adenocarcinoma and correlation with tumor progression
YS Shieh et al.
NEOPLASIA (2005)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival
PR van Ginkel et al.
CANCER RESEARCH (2004)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis
WP Lee et al.
ONCOGENE (2002)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
A Angelillo-Scherrer et al.
NATURE MEDICINE (2001)
Share Paper
